These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 15488812)
1. Effect of chronic systemic use of trimethoprim-sulfamethoxazole in the conjunctival bacterial flora of patients with HIV infection. Fontes BM; Muccioli C; Príncipe AH; Finamor LP; Höfling-Lima AL; Belfort R Am J Ophthalmol; 2004 Oct; 138(4):678-9. PubMed ID: 15488812 [TBL] [Abstract][Full Text] [Related]
2. Conjunctival flora in patients with human immunodeficiency virus infection. Yamauchi Y; Minoda H; Yokoi K; Maruyama K; Kumakura S; Usui M; Cruz JM; Fukutake K Ocul Immunol Inflamm; 2005; 13(4):301-4. PubMed ID: 16159721 [TBL] [Abstract][Full Text] [Related]
3. Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era. Martin JN; Rose DA; Hadley WK; Perdreau-Remington F; Lam PK; Gerberding JL J Infect Dis; 1999 Dec; 180(6):1809-18. PubMed ID: 10558935 [TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR; J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913 [TBL] [Abstract][Full Text] [Related]
5. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Milder E; Vander J; Shah C; Garg S Ophthalmology; 2012 Jul; 119(7):1420-4. PubMed ID: 22420958 [TBL] [Abstract][Full Text] [Related]
6. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ; Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703 [TBL] [Abstract][Full Text] [Related]
7. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Jordano Q; Falcó V; Almirante B; Planes AM; del Valle O; Ribera E; Len O; Pigrau C; Pahissa A Clin Infect Dis; 2004 Jun; 38(11):1623-8. PubMed ID: 15156452 [TBL] [Abstract][Full Text] [Related]
8. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine. Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617 [TBL] [Abstract][Full Text] [Related]
9. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections]. Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536 [TBL] [Abstract][Full Text] [Related]
10. Clonal groups and the spread of resistance to trimethoprim-sulfamethoxazole in uropathogenic Escherichia coli. France AM; Kugeler KM; Freeman A; Zalewski CA; Blahna M; Zhang L; Marrs CF; Foxman B Clin Infect Dis; 2005 Apr; 40(8):1101-7. PubMed ID: 15791508 [TBL] [Abstract][Full Text] [Related]
11. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin]. Bismuth R; Jarlier V; Grosset J Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335 [TBL] [Abstract][Full Text] [Related]
12. Prospective, randomized, multicentric, open, comparative study on the efficacy of a prophylactic single dose of 500 mg levofloxacin versus 1920 mg trimethoprim/sulfamethoxazole versus a control group in patients undergoing TUR of the prostate. Wagenlehner FM; Wagenlehner C; Schinzel S; Naber KG; Eur Urol; 2005 Apr; 47(4):549-56. PubMed ID: 15774257 [TBL] [Abstract][Full Text] [Related]
13. [The assessment of bacterial flora and antibiotic-sensitivity of bacteria isolated from conjunctival sac, skin of the eyelids and inflammatory lesions in patients with acne vulgaris and rosacea]. Kaszuba-Bartkowiak K; Goś R Przegl Lek; 2007; 64(12):991-6. PubMed ID: 18595500 [TBL] [Abstract][Full Text] [Related]
14. Blunted humoral response to influenza vaccination in patients exposed to zidovudine plus trimethoprim-sulfamethoxazole. Feola DJ; Garvy BA; Rapp RP; Thornton AC Pharmacotherapy; 2007 Jul; 27(7):937-47. PubMed ID: 17594199 [TBL] [Abstract][Full Text] [Related]
15. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection]. Piketty C; Gilqouin J; Kazatchkine M Ann Med Interne (Paris); 1996; 147(5):327-30. PubMed ID: 9033734 [TBL] [Abstract][Full Text] [Related]
17. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Grim SA; Rapp RP; Martin CA; Evans ME Pharmacotherapy; 2005 Feb; 25(2):253-64. PubMed ID: 15767239 [TBL] [Abstract][Full Text] [Related]
18. Effect of trimethoprim-sulfamethoxazole prophylaxis in AIDS patients on the formation of the small colony variant phenotype of Staphylococcus aureus. von Eiff C; Lubritz G; Heese C; Peters G; Becker K Diagn Microbiol Infect Dis; 2004 Mar; 48(3):191-4. PubMed ID: 15023428 [TBL] [Abstract][Full Text] [Related]
19. Bacteriologic profile of the conjunctiva in the patients with dry eye. Hori Y; Maeda N; Sakamoto M; Koh S; Inoue T; Tano Y Am J Ophthalmol; 2008 Nov; 146(5):729-34. PubMed ID: 18672220 [TBL] [Abstract][Full Text] [Related]
20. [Thiamphenicol versus trimethoprim-sulfamethoxazole in bacterial exacerbations of chronic unspecific respiratory tract diseases. A controlled study]. Medici TC; Hermann R; Lualdi P; Frigerio G Schweiz Med Wochenschr; 1980 Jul; 110(30):1128-37. PubMed ID: 6999618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]